Dudediligence.

Alumis Inc

ALMSNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$17.4MMar ’25$2.7MJun ’25$2.1MSep ’25$1.9MDec ’25$1.7MMar ’26$1.7MJun ’26
Net income, by quarter
−$93.1MSep ’24−$94.8MDec ’24−$99.0MMar ’25$59.3MJun ’25−$110.8MSep ’25−$92.9MDec ’25−$93.1MMar ’26−$142.2MJun ’26
Fiscal years, by the month each ended
LineDec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on filenone on filenone on file$24.1M
Operating incomenone on file−$158.2M−$300.8M−$453.8M
Net incomenone on file−$155.0M−$294.2M−$243.3M
Operating cash flownone on file−$130.0M−$255.1M−$369.5M
Free cash flownone on file−$134.5M−$256.8M−$370.2M
Cash$27.0M$46.0M$169.5M$89.7M
Shares outstandingnone on file2.2M28.3M85.0M